Insider Transactions in Q4 2021 at Evolent Health, Inc. (EVH)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2021
|
Frank J Williams Director |
SELL
Open market or private sale
|
Direct |
20,000
-1.69%
|
$520,000
$26.65 P/Share
|
|
Dec 17
2021
|
Frank J Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.65%
|
$30,000
$3.84 P/Share
|
|
Nov 17
2021
|
Frank J Williams Director |
SELL
Open market or private sale
|
Direct |
20,000
-1.66%
|
$540,000
$27.81 P/Share
|
|
Nov 17
2021
|
Frank J Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.62%
|
$30,000
$3.84 P/Share
|
|
Nov 01
2021
|
Tunde Sotunde Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,405
+50.0%
|
-
|
|
Oct 18
2021
|
Frank J Williams Director |
SELL
Open market or private sale
|
Direct |
20,000
-1.63%
|
$600,000
$30.35 P/Share
|
|
Oct 18
2021
|
Frank J Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.59%
|
$30,000
$3.84 P/Share
|
|
Oct 15
2021
|
Seth Blackley Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
150,000
-42.27%
|
$4,350,000
$29.86 P/Share
|
|
Oct 15
2021
|
Seth Blackley Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+29.71%
|
$450,000
$3.84 P/Share
|